Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Nov 15:418:117106.
doi: 10.1016/j.jns.2020.117106. Epub 2020 Sep 2.

Exacerbation of chronic inflammatory demyelinating polyneuropathy in concomitance with COVID-19

Samir Abu-Rumeileh  1 , Tamara Garibashvili  2 , Wolfgang Ruf  2 , Tanja Fangerau  2 , Jan Kassubek  2 , Katharina Althaus  2 , Markus Otto  2 , Makbule Senel  3
Affiliations
Comment

Exacerbation of chronic inflammatory demyelinating polyneuropathy in concomitance with COVID-19

Samir Abu-Rumeileh et al. J Neurol Sci. .

Abstract

  1. •

    A clinical worsening in CIDP may occur in concomitance with COVID-19.

  2. •

    Cytokine hyperactivation triggered by SARS-CoV-2 infection might be a possible mechanism.

  3. •

    The management of these patients is particularly challenging.

Keywords: CIDP; COVID-19; Coronavirus; Neuroimmunology; Neurology; SARS-CoV-2; myasthenia gravis; polyneuropathy.

PubMed Disclaimer

Conflict of interest statement

None.

Comment on

  • Myasthenic crisis in COVID-19.
    Delly F, Syed MJ, Lisak RP, Zutshi D. Delly F, et al. J Neurol Sci. 2020 Jul 15;414:116888. doi: 10.1016/j.jns.2020.116888. Epub 2020 May 6. J Neurol Sci. 2020. PMID: 32413767 Free PMC article.

References

    1. Delly F., Syed M.J., Lisak R.P., Zutshi D. Myasthenic crisis in COVID-19. J. Neurol. Sci. 2020;414 doi: 10.1016/j.jns.2020.116888. - DOI - PMC - PubMed
    1. Gilhus N.E., Romi F., Hong Y., Skeie G.O. Myasthenia gravis and infectious disease. J. Neurol. 2018;265(6):1251–1258. doi: 10.1007/s00415-018-8751-9. - DOI - PubMed
    1. Dimachkie M.M., Barohn R.J. Chronic inflammatory demyelinating polyneuropathy. Curr. Treat. Options Neurol. 2013;15(3):350–366. doi: 10.1007/s11940-013-0229-6. - DOI - PMC - PubMed
    1. Hughes R.A., Bouche P., Cornblath D.R., Evers E., Hadden R.D., Hahn A., Illa I., Koski C.L., Léger J.M., Nobile-Orazio E., Pollard J., Sommer C., Van den Bergh P., van Doorn P.A., van Schaik I.N. European Federation of Neurological Societies/peripheral nerve society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the peripheral nerve society. Eur. J. Neurol. 2006 Apr;13(4):326–332. - PubMed
    1. Lünemann J.D., Tackenberg B., Stein A. Dysregulated Epstein-Barr virus infection in patients with CIDP. J. Neuroimmunol. 2010;218(1–2):107–111. doi: 10.1016/j.jneuroim.2009.11.003. - DOI - PubMed